Sinopharm Group Co. Ltd. (FRA:X2S)

Market Cap	6.65B -2.3%
Revenue (ttm)	72.26B -1.6%
Net Income	894.61M +1.5%
EPS	0.29 +1.5%
Shares Out	n/a
PE Ratio	7.43
Forward PE	6.78
Dividend	0.08 (3.65%)
Ex-Dividend Date	Jun 16, 2025

Volume	50
Average Volume	68
Open	2.121
Previous Close	2.144
Day's Range	2.121 - 2.121
52-Week Range	1.965 - 2.374
Beta	n/a
RSI	35.84
Earnings Date	Apr 24, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 94,910
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X2S

Financial Performance

In 2025, Sinopharm Group's revenue was 575.17 billion, a decrease of -1.60% compared to the previous year's 584.51 billion. Earnings were 7.16 billion, an increase of 1.50%.

Financial numbers in CNY